Stock Events

Stock Events

TC BioPharm (Holdings) 

$0.001800
55
+$0.00+0% Wednesday 18:18

Statistics

Day High
0.0032
Day Low
0.0032
52W High
0.0032
52W Low
0.0018
Volume
3,333
Avg. Volume
-
Mkt Cap
4.59M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
0Revenue
-7.52MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Allogene Therapeutics
ALLO
Mkt Cap680.62M
Allogene Therapeutics, Inc. works on allogeneic CAR T therapies for cancer, competing in the cell therapy space.
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
CRISPR Therapeutics AG is involved in gene editing and cell therapy for cancer, directly competing in the innovative treatment space.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences, Inc. has a strong presence in cell therapy for cancer through its subsidiary Kite Pharma, making it a direct competitor.
Novartis
NVS
Mkt Cap304.1B
Novartis AG has approved CAR T-cell therapies in the market, making it a leading competitor in the cell therapy space.
Precigen
PGEN
Mkt Cap2.54B
Precigen, Inc. focuses on gene and cell therapies, including CAR T-cell therapies, competing in the same innovative treatment sector.

About

TC BIOPHARM (HLDGS) WTS
Show more...
CEO
Mr. Bryan Leland Kobel
Country
United Kingdom
ISIN
US87807D1110

Listings

OTC Link
US
TCBWF
STU
DE
T0U0.STU

0 Comments

Share your thoughts

FAQ

What is TC BioPharm (Holdings) stock price today?▼
The current price of TCBWF is $0.00 USD — it has increased by +0% in the past 24 hours. Watch TC BioPharm (Holdings) stock price performance more closely on the chart.
What is TC BioPharm (Holdings) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange TC BioPharm (Holdings) stocks are traded under the ticker TCBWF.
What is TC BioPharm (Holdings) market cap?▼
Today TC BioPharm (Holdings) has the market capitalization of 4.59M
What is TC BioPharm (Holdings) revenue for the last year?▼
TC BioPharm (Holdings) revenue for the last year amounts to 0 USD.
What is TC BioPharm (Holdings) net income for the last year?▼
TCBWF net income for the last year is -7.52M USD.
In which sector is TC BioPharm (Holdings) located?▼
TC BioPharm (Holdings) operates in the Other sector.
When did TC BioPharm (Holdings) complete a stock split?▼
TC BioPharm (Holdings) has not had any recent stock splits.
Where is TC BioPharm (Holdings) headquartered?▼
TC BioPharm (Holdings) is headquartered in Motherwell, United Kingdom.